WYMM Tour: Los Angeles
November 14 2024, 9:00 AM - 3:30 PM PST
Los Angeles, United States

WYMM Tour: Los Angeles

Thursday, November 14, 2024, 09:00 am-05:00 pm PST - Los Angeles, California

Generate ultra-rich data for answers with impact.

Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.​​

Join us on Thursday, November 14, 2024 at the Albert Ballroom of the SLS Hotel Beverly Hills to hear from local experts who are breaking new ground in human genomics, using nanopore technology.​​​

What you're missing matters. Stay on top of what's next.​

Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.

Please note that this is an in-person event.

There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.

Full agenda coming soon.

Register

Agenda

Los Angeles, United States

09:00 am-04:30 pm EST

Agenda (subject to change)

Speaker

09:00 am-09:30 am

Registration and breakfast​

09:30 am-09:35 am

Welcome

Andy O'Shaughnessy, Oxford Nanopore Technologies

09:35 am-10:00 am

Oxford Nanopore latest and greatest updates

Alan Silverman, Oxford Nanopore Technologies

10:00 am-10:30 am

Therapy resistance of high grade serous ovarian cancer established early in tumor development.

Michael Diaz, Cedars-Sinai Medical Center

10:30 am-11:00 am

Networking session

11:00 am-11:30 am

Epigenome alterations via glucose-regulated O-GlcNAcylation of DNMT1

Dustin Schones, City of Hope

11:30 am-12:00 pm

ONT sequencing is capable of detecting constitutional MLH1 methylation and linking to genetic haplotypes in Lynch syndrome

Megan P. Hitchins, Cedars-Sinai Medical Center

12:00 pm-01:00 pm

Lunch

01:00 pm-01:30 pm

Bridging long read and short read to understand variation

Jasmine Sakr, University of California, Irvine

01:30 pm-02:00 pm

Accelerating biotechnology with seamless sequencing

Jim Stapleton, Plasmidsaurus

02:00 pm-02:15 pm

Networking session

02:15 pm-02:45 pm

Building an Artificial Kidney by Deconstructing and Reconstructing Development

Nils Lindström, University of Southern California

02:45 pm-03:15 pm

Oxford Nanopore Bioinformatics updates

Rebecca Stubbs, Oxford Nanopore Technologies

03:15 pm-03:30 pm

Closing Remarks

Andy O'Shaughnessy, Oxford Nanopore Technologies

03:30 pm-04:30 pm

Networking session

Speakers

picture of Andy O'Shaughnessy

Welcome

Andy O'Shaughnessy, Senior Director, Technical Services, Oxford Nanopore Technologies

...

Oxford Nanopore latest and greatest updates

Alan Silverman, Regional Sequencing Specialist, Oxford Nanopore Technologies

...

picture of Michael Diaz

Therapy resistance of high grade serous ovarian cancer established early in tumor development.

Michael Diaz, Bioinformatician, Cedars Sinai

I am a recent Ph.D. graduate from Cedars Sinai that studied genomic profiling of matched primary and...

picture of Dustin Schones

Epigenome alterations via glucose-regulated O-GlcNAcylation of DNMT1

Dustin Schones, Associate Professor, Department of Diabetes Complications and Metabolism, City of Hope

Dr. Schones is interested in the epigenetic regulation of the genome and how epigenetic modification...

picture of Megan P. Hitchins

ONT sequencing is capable of detecting constitutional MLH1 methylation (epimutation) and linking methylation to extended genetic haplotypes in Lynch syndrome cases.

Megan P. Hitchins, Professor, Director for Translational Genomics, Department of Biochemistry, Cedars-Sinai Medical Center

Professor Megan Hitchins is a cancer geneticist and epigeneticist with a research focus on unusual o...

Bridging long read and short read to understand variation

Jasmine Sakr, University of California, Irvine

...

picture of James Stapleton

Accelerating biotechnology with seamless sequencing

James Stapleton, CTO, Plasmidsaurus

Jim Stapleton is a co-founder and CTO of Plasmidsaurus. He has a PhD in chemical engineering and is ...

picture of Nils Lindstrom

Building an Artificial Kidney by Deconstructing and Reconstructing Development

Nils Lindstrom, Assistant Professor in Stem Cell Biology and Regenerative Medicine Director CIRM ASCEND Shared Resource Laboratory Faculty Director Optical Imaging Facility Broad CIRM Center for Regenerative Medicine and Stem Cell Research , University of Southern California

Dr. Nils Lindström earned his Ph.D. in developmental biology at the University of Edinburgh detailin...

picture of Rebecca Stubbs

Calling disease variants in human samples using automated EPI2ME end-to-end workflows

Rebecca Stubbs, Genomic Applications Bioinformatician, Oxford Nanopore Technologies

...